New Screening Tool Unveils Impact of Disease-Causing Mutations
Wellcome Trust Sanger Institute
Integrated single-cell approach to cellular genetic screening uncovers mechanisms driving cancer and autoimmunity
Individuals who received two mg or three mg of Rexulti showed statistically significant and clinically meaningful improvements